Literature DB >> 8204475

Management and follow-up of harlequin siblings.

R S Prasad1, R K Pejaver, A Hassan, S al Dusari, M A Wooldridge.   

Abstract

Harlequin fetus is a rare clinical entity, and survival of affected infants beyond the first year of life is uncommon. Management involves intensive care of the skin and eyes, close monitoring of fluid and electrolyte status, constant support and counselling of parents, and surveillance against infection and side-effects of medication. A well-coordinated multidisciplinary approach can prolong survival beyond the neonatal period. We report our experiences in the management and follow-up of two successive harlequin siblings.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8204475     DOI: 10.1111/j.1365-2133.1994.tb13114.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  2 in total

1.  Etretinate in the management of harlequin siblings.

Authors:  R K Pejaver; R S Prasad; A K Garg; A Jelly; S Shawkat
Journal:  Indian J Pediatr       Date:  1998 Mar-Apr       Impact factor: 1.967

2.  Self-improvement of keratinocyte differentiation defects during skin maturation in ABCA12-deficient harlequin ichthyosis model mice.

Authors:  Teruki Yanagi; Masashi Akiyama; Hiroshi Nishihara; Junko Ishikawa; Kaori Sakai; Yuki Miyamura; Ayano Naoe; Takashi Kitahara; Shinya Tanaka; Hiroshi Shimizu
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.